Wood-smoke exposure (WSE) as a predictor of response and survival in erlotinib-treated non-small cell lung cancer (NSCLC) patients

J Thorac Oncol. 2009 Jan;4(1):142-3. doi: 10.1097/JTO.0b013e3181915fb6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / mortality
  • ErbB Receptors / antagonists & inhibitors
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Inhalation Exposure*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*
  • Smoke*
  • Survival Rate
  • Wood*

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Smoke
  • Erlotinib Hydrochloride
  • ErbB Receptors